Why is Pharmaids Pharma falling/rising?

As of 02-Sep, Pharmaids Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 62.90, which reflects a rise of 2.0 or 3.28%. The stock has shown positive momentum, gaining for the last two days with a total return of 7.23% during this period. Despite a day’s low of Rs 59.18, the stock reached an intraday high of Rs 63, outperforming its sector by 3.35%. However, it is important to note that the stock has a weak long-term fundamental strength, with operating losses and a negative EBITDA, which raises concerns about its sustainability despite a 49.76% return over the past year.
In the broader market context, the stock's short-term performance contrasts with the benchmark, as it has gained 0.80% over the past week while the Sensex has declined by 0.78%. Although Pharmaids has outperformed the benchmark in the short term, its year-to-date performance shows a decline of 10.75%, while the Sensex has increased by 2.58%. This divergence highlights the stock's volatility and the risks associated with its financial health, particularly given the high debt-to-EBITDA ratio and declining profits, which could impact investor confidence moving forward.